Global Kidney Cancer Diagnostics Market Size to Exceed USD 8.36 Billion by 2035 | CAGR of 4.11%
Category: HealthcareGlobal Kidney Cancer Diagnostics Market Size to Exceed USD 8.36 Billion by 2035
According to a Research Report Published by Spherical Insights & Consulting, The Global Kidney Cancer Diagnostics Market Size is expected to Grow from USD 5.37 Billion in 2024 to USD 8.36 Billion by 2035, at a CAGR of 4.11% during the forecast period 2025-2035.
Get more details on this report -
Browse 210 Market Data Tables And 45 Figures Spread Through 190 Pages and In-Depth TOC On the "Global Kidney Cancer Diagnostics Market Size, Share, and COVID-19 Impact Analysis, By Test (Immunohistochemistry, Complete Blood Count, Urine Test, and Blood Chemistry), By Indication (Renal Cell Carcinoma, Transitional Cell Carcinoma, Kidney Sarcoma, Wilms Tumor, and Kidney Lymphoma), By End-User (Hospital-Associated Labs, Independent Diagnostic Laboratories, Cancer Research Institutes, and Others), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2025 – 2035." Get Detailed Report Description Here: https://www.sphericalinsights.com/reports/kidney-cancer-diagnostics-market
The kidney cancer diagnostics market refers to the cancer diagnostic industry that focuses on the development and sale of the medical tools, technologies, and services used for early detection, diagnosis, staging, and monitoring of kidney cancer. Kidney cancer diagnostics involve the medical history and physical examination. The tests include urine analysis, blood tests, CT scan, MRI scan, ultrasound, chest x-ray, angiography, bone scan, and kidney biopsy. Awareness among patients about kidney health leads to driving the demand for early diagnosis in order to detect the diseases at the initial stage. Technological advancements and innovations in diagnostic solutions are improving the ability of diagnostic tools, which are bolstering market growth opportunities. An increasing prevalence of kidney cancer, awareness about early diagnostics, and technological advancements in diagnostic devices are responsible for driving the market growth. On the contrary, the lack of awareness and increasing cost are limiting the kidney cancer diagnostics market.
The immunohistochemistry segment dominated the market with the largest share in 2024 and is projected to grow at a substantial CAGR during the forecast period.
Based on the test, the kidney cancer diagnostics market is divided into immunohistochemistry, complete blood count, urine test, and blood chemistry. Among these, the immunohistochemistry segment dominated the market with the largest share in 2024 and is projected to grow at a substantial CAGR during the forecast period. Immunohistochemistry aids in identifying specific protein markers on cancer cells within a sample, revealing the exact type and subtype of cancer.
The renal cell carcinoma segment accounted for the largest market share in 2024 and is anticipated to grow at a remarkable CAGR during the forecast period.
Based on the indication, the kidney cancer diagnostics market is divided into renal cell carcinoma, transitional cell carcinoma, kidney sarcoma, Wilms tumor, and kidney lymphoma. Among these, the renal cell carcinoma segment accounted for the largest market share in 2024 and is anticipated to grow at a remarkable CAGR during the forecast period. Diagnostic techniques like CT/MRI imaging, immunohistochemistry, and molecular biomarker testing are used for the diagnosis of renal cell carcinoma. Lifestyle-related factors and certain medications that are responsible for causing renal cell carcinoma are driving the market demand.
The hospital-associated labs segment accounted for the largest share in 2024 and is anticipated to grow at a significant CAGR during the forecast period.
Based on the end-user, the kidney cancer diagnostics market is divided into hospital-associated labs, independent diagnostic laboratories, cancer research institutes, and others. Among these, the hospital-associated labs segment accounted for the largest share in 2024 and is anticipated to grow at a significant CAGR during the forecast period. The availability of multidisciplinary oncology teams for prompt testing and treatment decisions is responsible for driving the market in the hospital-associated labs segment.
North America is expected to hold the majority share of the global kidney cancer diagnostics market during the forecast period.
Get more details on this report -
North America is expected to hold the majority share of the global kidney cancer diagnostics market during the forecast period. An increasing awareness about kidney cancer, along with increasing healthcare expenditure for diagnostic solutions, are contributing factors for driving the market. Further, the availability of well-established healthcare infrastructure is responsible for market growth for kidney cancer diagnostics.
Asia Pacific is anticipated to grow at the fastest pace in the global kidney cancer diagnostics market during the forecast period. The growing prevalence of kidney cancer and patient awareness in countries like China, India, and Japan are propelling market demand. Further, an increasing R&D activity for developing cost-effective, portable, and non-invasive testing solutions is anticipated to drive the kidney cancer diagnostics market.
Major vendors in the global kidney cancer diagnostics market are Myriad Genetics Inc., NeoGenomics Laboratories, NanoString Technologies Inc., Sysmex Corporation, Rosetta Genomics, Illumina Inc., Glenmark, Cobolong, Quest Diagnostics Incorporated, Roche Holding AG, Thermo Fisher Scientific Inc., Abbott Laboratories, and Others.
Key Target Audience
- Market Players
- Investors
- End-users
- Government Authorities
- Consulting and Research Firm
- Venture capitalists
- Value-Added Resellers (VARs)
Key Market Development
- In September 2025, according to a new study announced at the 39th annual International Bubble Conference, contrast-enhanced ultrasound (CEUS) is superior to contrast magnetic resonance (MR) and computed tomography (CT), and offers 100% sensitivity and specificity, for finding residual or recurrent kidney tumors in patients who have had a kidney-sparing procedure.
Market Segment
This study forecasts revenue at global, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the kidney cancer diagnostics market based on the below-mentioned segments:
Global Kidney Cancer Diagnostics Market, By Test
- Immunohistochemistry
- Complete Blood Count
- Urine Test
- Blood Chemistry
Global Kidney Cancer Diagnostics Market, By Indication
- Renal Cell Carcinoma
- Transitional Cell Carcinoma
- Kidney Sarcoma
- Wilms Tumor
- Kidney Lymphoma
Global Kidney Cancer Diagnostics Market, By End-User
- Hospital-associated Labs
- Independent Diagnostic Laboratories
- Cancer Research Institutes
- Others
Global Kidney Cancer Diagnostics Market, By Regional Analysis
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Rest of Asia Pacific
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- UAE
- Saudi Arabia
- Qatar
- South Africa
- Rest of the Middle East & Africa
About the Spherical Insights & Consulting
Spherical Insights & Consulting is a market research and consulting firm which provides actionable market research study, quantitative forecasting and trends analysis provides forward-looking insight especially designed for decision makers and aids ROI.
Which is catering to different industry such as financial sectors, industrial sectors, government organizations, universities, non-profits and corporations. The company's mission is to work with businesses to achieve business objectives and maintain strategic improvements.
CONTACT US:
For More Information on Your Target Market, Please Contact Us Below:
Phone: +1 303 800 4326 (the U.S.)
Phone: +91 90289 24100 (APAC)
Email: inquiry@sphericalinsights.com, sales@sphericalinsights.com
Contact Us: https://www.sphericalinsights.com/contact-us
Need help to buy this report?